These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 14038965)

  • 1. Biochemical studies on the DAB-hepatocarcinogenesis. Comparative studies on normal rat liver, AH 130 ascites hepatoma and 3'-me-DAB-hepatoma especially at the level of subcellular particulates.
    SATO K
    Sci Rep Res Inst Tohoku Univ Med; 1961 Sep; 10():249-63. PubMed ID: 14038965
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparative study of glycolipid metabolism in two types of rat ascites hepatoma cells.
    Taki T; Hirabayashi Y; Kanki Y; Matsumoto M; Kojima K
    Jpn J Exp Med; 1977 Oct; 47(5):429-33. PubMed ID: 202768
    [No Abstract]   [Full Text] [Related]  

  • 3. [Histochemical and biochemical studies on the effects of anticancer agents on glycogen metabolism in AH13 ascites hepatoma].
    Sudo I
    Kumamoto Igakkai Zasshi; 1969 Apr; 43(4):277-96. PubMed ID: 4308494
    [No Abstract]   [Full Text] [Related]  

  • 4. [Fluorochromization with ethidium bromide in cells with Yoshida ascites hepatoma].
    Raimondi L; Roveta G; Basso Ricci L
    Riv Istochim Norm Patol; 1974; 18(1-4):25-8. PubMed ID: 4377829
    [No Abstract]   [Full Text] [Related]  

  • 5. The differences between the primary structures of mitochondrial DNAs from rat liver and ascites hepatoma (AH-130).
    Hayashi JI; Yonekawa H; Gotoh O; Motohashi J; Tagashira Y
    Cancer Lett; 1978 Mar; 4(3):125-30. PubMed ID: 206346
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transforming growth factor-beta1 induces LMO7 while enhancing the invasiveness of rat ascites hepatoma cells.
    Nakamura H; Mukai M; Komatsu K; Tanaka-Okamoto M; Itoh Y; Ishizaki H; Tatsuta M; Inoue M; Miyoshi J
    Cancer Lett; 2005 Mar; 220(1):95-9. PubMed ID: 15737692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nutritional requirements of rat ascites hepatoma cells of strain JTC-16 (AH-7974) in tissue culture.
    Ota S; Takaoka T; Katsuta H
    Jpn J Exp Med; 1969 Aug; 39(4):359-70. PubMed ID: 4313328
    [No Abstract]   [Full Text] [Related]  

  • 8. Changes in back-transplantability by fluid-suspension culture and by long-term of cultivation of two tissue culture cell strains, JTC-1 and JTC-2, originated from rat ascites hepatoma AH-130.
    Katsuta H; Takaoka T; Ito K; Okumura H
    Jpn J Exp Med; 1973 Dec; 43(6):483-93. PubMed ID: 4361510
    [No Abstract]   [Full Text] [Related]  

  • 9. [Various biochemical properties of DAB DAB-induced hepatomas. B. Ribonucleic acid content].
    PILERI A; LEDOUX L; POZNANSKA H
    Rev Fr Etud Clin Biol; 1958 Oct; 3(8):890-1. PubMed ID: 13614964
    [No Abstract]   [Full Text] [Related]  

  • 10. Deregulation of the activin/follistatin system in hepatocarcinogenesis.
    Grusch M; Drucker C; Peter-Vörösmarty B; Erlach N; Lackner A; Losert A; Macheiner D; Schneider WJ; Hermann M; Groome NP; Parzefall W; Berger W; Grasl-Kraupp B; Schulte-Hermann R
    J Hepatol; 2006 Nov; 45(5):673-80. PubMed ID: 16935389
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of apolipoprotein A-1 containing steroid hormones on DNA and protein biosynthesis in cells of ascitic hepatoma HA-1].
    Panin LE; Khoshchenko OM; Poliakov LM
    Vopr Onkol; 2007; 53(5):562-5. PubMed ID: 18154121
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative study of glycolipid compositions of plasma membranes among two types of rat ascites hepatoma and normal rat liver.
    Taki T; Hirabayashi Y; Suzuki Y; Matsumoto M; Kojima K
    J Biochem; 1978 May; 83(5):1517-20. PubMed ID: 207687
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic resistance to chemical hepatocarcinogenesis in the DRH rat strain.
    Higashi K; Denda A; Higashi T; Hiai H
    Comp Med; 2004 Aug; 54(4):373-7. PubMed ID: 15357316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and analysis of glycopeptides from microsomes of an ascites hepatoma, AH 66.
    Funakoshi I; Yamashina I
    J Biochem; 1972 Aug; 72(2):459-67. PubMed ID: 4345433
    [No Abstract]   [Full Text] [Related]  

  • 15. Relationship between elevated FX expression and increased production of GDP-L-fucose, a common donor substrate for fucosylation in human hepatocellular carcinoma and hepatoma cell lines.
    Noda K; Miyoshi E; Gu J; Gao CX; Nakahara S; Kitada T; Honke K; Suzuki K; Yoshihara H; Yoshikawa K; Kawano K; Tonetti M; Kasahara A; Hori M; Hayashi N; Taniguchi N
    Cancer Res; 2003 Oct; 63(19):6282-9. PubMed ID: 14559815
    [TBL] [Abstract][Full Text] [Related]  

  • 16. c-myc overexpression in hepatocarcinogenesis.
    Feitelson MA
    Hum Pathol; 2004 Nov; 35(11):1299-302. PubMed ID: 15668885
    [No Abstract]   [Full Text] [Related]  

  • 17. 2-Methoxyestradiol inhibits hepatocellular carcinoma cell growth by inhibiting Cdc25 and inducing cell cycle arrest and apoptosis.
    Kar S; Wang M; Carr BI
    Cancer Chemother Pharmacol; 2008 Oct; 62(5):831-40. PubMed ID: 18246350
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Synthesis of glutathione by hepatoma and ascites carcinoma cells].
    PIKKAT AK
    Vopr Med Khim; 1956; 2(5):323-7. PubMed ID: 13392576
    [No Abstract]   [Full Text] [Related]  

  • 19. Androgen receptor and hepatocarcinogenesis: what do we learn from HCC mouse models?
    Zender L; Kubicka S
    Gastroenterology; 2008 Sep; 135(3):738-40. PubMed ID: 18692055
    [No Abstract]   [Full Text] [Related]  

  • 20. Comparative studies on the phosphatides of normal rat liver and primary hepatoma.
    VEERKAMP JH; MULDER I; van DEENEN L
    Z Krebsforsch; 1961; 64():137-48. PubMed ID: 13780574
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.